A Randomised Controlled Trial of Self-help Mindfulness-based Cognitive Therapy for Health Workers
NCT ID: NCT03030040
Last Updated: 2019-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2017-01-26
2018-06-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining the Feasibility of a Mindfulness Booster Course for Healthcare Staff Who Attended an 8-week Mindfulness Course
NCT05721716
The Influence of Mindfulness on the Link Between Consumer Culture Values and Well-being
NCT03079154
Effects of a Mindfulness Meditation App on Subjective Well-Being in Undergraduate University Students
NCT03783793
Self-help Books for Student Mental Health
NCT03779412
Comparing Random Allocation and Allocation by Preference to Mindfulness Practice
NCT06402461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Hypothesis
-Mindfulness-based cognitive therapy self-help (MBCT-SH) participants, in comparison to waitlist control participants, will show a reduction in symptoms of stress by the end of MBCT-SH (week 9).
Secondary Hypotheses
* The improvement detailed in the primary hypothesis will be maintained at a follow-up 12 weeks after the end of the MBCT-SH (week 21).
* MBCT-SH participants, in comparison to waitlist control participants, will show improvements in mindfulness, other-compassion, self-compassion, anxiety, depression, burnout and mental well-being by the end of MBCT-SH (week 9), and these improvements will be maintained at a follow-up 12 weeks after the end of the MBCT-SH (week 21).
* MBCT-SH participants, in comparison to waitlist control participants, will show a reduction in the number of sickness absence days from the three months preceding the intervention to the three months following the intervention.
* Increases in self-compassion and mindfulness from week 0 to week 9, will mediate the effects of MBCT-SH (relative to waitlist control) on levels of stress, depression, anxiety, wellbeing and burnout.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MBCT-SH
MBCT-SH will be an unguided, mindfulness-based cognitive therapy, book-based self-help intervention.
The self-help book: Williams, M. & Penman, D. (2011). Mindfulness: A practical guide to finding peace in a frantic world. London: Piatkus.
Participants will be provided with a copy of the self-help book, and asked to read it and follow the activities outlined in it, over eight weeks. They will receive weekly standardized emails, to provide information about mindfulness and encouragement to engage with the self-help book.
Control
A wait list control group who will receive no intervention during the 21 weeks of the study. Control participants will be provided with the self-help book that the MBCT-SH group received after week 21.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The self-help book: Williams, M. & Penman, D. (2011). Mindfulness: A practical guide to finding peace in a frantic world. London: Piatkus.
Participants will be provided with a copy of the self-help book, and asked to read it and follow the activities outlined in it, over eight weeks. They will receive weekly standardized emails, to provide information about mindfulness and encouragement to engage with the self-help book.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Having at least one day per week of direct contact with UK National Health Service service users.
3. Agreeing to refrain from engaging in another form of psychological therapy during the course of the study.
4. Having self-reported sufficient English language reading ability to read and understand the self-help book
Exclusion Criteria
2. Having previously received a minimum dose (defined as 50% of a course or more) of a mindfulness-based intervention.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sussex Partnership NHS Foundation Trust
OTHER
University of Sussex
OTHER
Canterbury Christ Church University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily C Ironmonger, MSc
Role: PRINCIPAL_INVESTIGATOR
Canterbury Christ Church University
Clara Strauss, PhD
Role: STUDY_DIRECTOR
Sussex Partnership NHS Foundation Trust & University of Sussex
Kate Cavanagh, PhD
Role: STUDY_DIRECTOR
University of Sussex
Fergal Jones, PhD
Role: STUDY_DIRECTOR
Canterbury Christ Church University & Sussex Partnership NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oxleas NHS Foundation Trust
Dartford, Kent, United Kingdom
Sussex Partnership NHS Foundation Trust
Hove, Sussex, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRAS ID: 215054
Identifier Type: OTHER
Identifier Source: secondary_id
EmilyIronmongerMRP2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.